377 related articles for article (PubMed ID: 11823785)
21. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
22. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
Chaudhuri J; Khuong C; Alt FW
Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
[TBL] [Abstract][Full Text] [Related]
23. Activation-induced deaminase: light and dark sides.
de Yébenes VG; Ramiro AR
Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
[TBL] [Abstract][Full Text] [Related]
24. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
[TBL] [Abstract][Full Text] [Related]
25. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes.
Mayorov VI; Rogozin IB; Adkison LR; Frahm C; Kunkel TA; Pavlov YI
BMC Immunol; 2005 Jun; 6():10. PubMed ID: 15949042
[TBL] [Abstract][Full Text] [Related]
26. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
Arakawa H; Hauschild J; Buerstedde JM
Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
[TBL] [Abstract][Full Text] [Related]
27. Involvement of DNase gamma in the resected double-strand DNA breaks in immunoglobulin genes.
Okamoto M; Okamoto N; Yashiro H; Shiokawa D; Sunaga S; Yoshimori A; Tanuma S; Kitamura D
Biochem Biophys Res Commun; 2005 Feb; 327(1):76-83. PubMed ID: 15629432
[TBL] [Abstract][Full Text] [Related]
28. AID-initiated purposeful mutations in immunoglobulin genes.
Goodman MF; Scharff MD; Romesberg FE
Adv Immunol; 2007; 94():127-55. PubMed ID: 17560274
[TBL] [Abstract][Full Text] [Related]
29. AID mutant analyses indicate requirement for class-switch-specific cofactors.
Ta VT; Nagaoka H; Catalan N; Durandy A; Fischer A; Imai K; Nonoyama S; Tashiro J; Ikegawa M; Ito S; Kinoshita K; Muramatsu M; Honjo T
Nat Immunol; 2003 Sep; 4(9):843-8. PubMed ID: 12910268
[TBL] [Abstract][Full Text] [Related]
30. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
31. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
Rückerl F; Busse B; Bachl J
Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
[TBL] [Abstract][Full Text] [Related]
32. Reflections on the state of play in somatic hypermutation.
Steele EJ
Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
[TBL] [Abstract][Full Text] [Related]
33. Targeting of somatic hypermutation.
Odegard VH; Schatz DG
Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
[TBL] [Abstract][Full Text] [Related]
34. Rapid cell division contributes to efficient induction of A/T mutations during Ig gene hypermutation.
Kano C; Ouchida R; Kokubo T; Wang JY
Mol Immunol; 2011 Sep; 48(15-16):1993-9. PubMed ID: 21724261
[TBL] [Abstract][Full Text] [Related]
35. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
Rückerl F; Bachl J
Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
[TBL] [Abstract][Full Text] [Related]
36. Preferential targeting of somatic hypermutation to hotspot motifs and hypermutable sites and generation of mutational clusters in the IgVH alleles of a rheumatoid factor producing lymphoblastoid cell line.
Laskov R; Yahud V; Hamo R; Steinitz M
Mol Immunol; 2011 Feb; 48(5):733-45. PubMed ID: 21194753
[TBL] [Abstract][Full Text] [Related]
37. Methylation protects cytidines from AID-mediated deamination.
Larijani M; Frieder D; Sonbuchner TM; Bransteitter R; Goodman MF; Bouhassira EE; Scharff MD; Martin A
Mol Immunol; 2005 Mar; 42(5):599-604. PubMed ID: 15607819
[TBL] [Abstract][Full Text] [Related]
38. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
[TBL] [Abstract][Full Text] [Related]
39. Activation-induced cytidine deaminase induces DNA break repair events more frequently in the Ig switch region than other sites in the mammalian genome.
Lee SA; Parsa JY; Martin A; Baker MD
Eur J Immunol; 2007 Dec; 37(12):3529-39. PubMed ID: 18034427
[TBL] [Abstract][Full Text] [Related]
40. Possible contribution of DNase gamma to immunoglobulin V gene diversification.
Okamoto N; Okamoto M; Araki S; Arakawa H; Mizuta R; Kitamura D
Immunol Lett; 2009 Jun; 125(1):22-30. PubMed ID: 19501119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
